BMSO: A Novel Sulfoxide-Containing Cleavable Cysteine Crosslinker

Tech ID: 33945 / UC Case 2019-658-0

Brief Description

BMSO represents a groundbreaking advancement in crosslinking mass spectrometry (XL-MS), enabling comprehensive mapping of protein-protein interactions.

Full Description

BMSO, or bis-maleimide sulfoxide, is a cutting-edge cysteine-reactive crosslinker designed to enhance the identification of cysteine crosslinked peptides in protein-protein interaction (PPI) studies. By incorporating a sulfoxide-containing spacer arm that is mass spectrometry (MS)-cleavable, BMSO enables straightforward and unambiguous identification of crosslinked peptides, significantly advancing the capabilities of crosslinking mass spectrometry (XL-MS) for studying complex protein architectures and interactions.

Suggested uses

  • Proteomics research for detailed protein interaction mapping. 
  • Structural biology for elucidating protein complex architectures. 
  • Drug discovery and development for identifying potential therapeutic targets. 
  • Biomedical research for understanding disease mechanisms at the molecular level.

Advantages

  • Proteomics research for detailed protein interaction mapping. 
  • Structural biology for elucidating protein complex architectures. 
  • Drug discovery and development for identifying potential therapeutic targets. 
  • Biomedical research for understanding disease mechanisms at the molecular level.

Patent Status

Country Type Number Dated Case
United States Of America Published Application 20210253524 08/19/2021 2019-658
 

Related Materials

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information

Categorized As


5270 California Avenue / Irvine,CA
92697-7700 / Tel: 949.824.2683
  • Facebook
  • Twitter
  • Twitter
  • Twitter
  • Twitter